CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Atara Biotherapeutics's Quick Ratio for Trailing Twelve Months Period

ATRA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth



ATRA Quick Ratio for Trailing Twelve Months Period

(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
(Sep 30 2017)
III. Quarter
(Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
Y / Y Current Liabilities Growth 88.51 % 144.34 % 20.66 % 14.74 % -11.91 %
Y / Y Cash & cash equivalent Growth 76.54 % -35.04 % -27.95 % -26.3 % -24.66 %
Quick Ratio for Trailing Twelve Months Period 14.94 13.7 19.88 23.02 25.73
Total Ranking # 152 # 157 # 84 # 67 # 58
Seq. Current Liabilities Growth -37.76 % 43.13 % 43.86 % 47.1 % -19.33 %
Seq. Cash & cash equivalent Growth 145.35 % -17.12 % -7.68 % -5.96 % -9.72 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Atara Biotherapeutics, Inc. Cash & cash equivalent average soared by 76.54 % in I. Quarter year on year, faster than Current Liabilities, this led to increase in in Atara Biotherapeutics's Quick Ratio for Trailing Twelve Months Period to 14.94, Quick Ratio for Trailing Twelve Months Period remained below Atara Biotherapeutics, Inc. average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry 13 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Atara Biotherapeutics. While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 152, from total ranking in previous quarter at 157.

What is Quick Ratio?
Learn more about ATRA
Quick Ratio ATRA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 14
Sector # 47
S&P 500 # 147


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
35.85 25.85 12.84
(June 30. 2016)   (Dec 31 2017)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2018, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Regenxbio Inc.  38.99 
Kubota Pharmaceutical Holdings Co Ltd  34.17 
Lion Biotechnologies, Inc.  26.75 
Enzon Pharmaceuticals, Inc.  20.67 
Novus Therapeutics, Inc.  20.25 
Gtx Inc  19.03 
Crispr Therapeutics Ag  18.54 
Fennec Pharmaceuticals Inc.  17.90 
Atara Biotherapeutics, Inc.  17.72 
Iovance Biotherapeutics, Inc.  17.09 
Microbot Medical Inc.  14.86 
Acceleron Pharma Inc  14.45 
Aclaris Therapeutics, Inc.  14.33 
Aerie Pharmaceuticals Inc  14.15 
Pulse Biosciences, Inc.  13.88 
Voyager Therapeutics, Inc.  13.86 
Neuralstem, Inc.  13.40 
G1 Therapeutics, Inc.  12.45 
Allena Pharmaceuticals, Inc.  12.23 
Audentes Therapeutics, Inc.  11.99 
Bluebird Bio, Inc.  11.70 
Neurocrine Biosciences Inc  11.41 
La Jolla Pharmaceutical Co  11.32 
Organovo Holdings, Inc.  11.19 
Casi Pharmaceuticals, Inc.  11.12 
Intellia Therapeutics, Inc.  10.78 
Idera Pharmaceuticals, Inc.  10.65 
Anavex Life Sciences Corp.  10.52 
Alder Biopharmaceuticals Inc  9.95 
Artemis Therapeutics, Inc.  9.86 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IPWR's Profile

Stock Price

IPWR's Financials

Business Description

Fundamentals

Charts & Quotes

IPWR's News

Suppliers

IPWR's Competitors

Customers & Markets

Economic Indicators

IPWR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071